Adelene Q. Perkins

2013

In 2013, Adelene Q. Perkins earned a total compensation of $3.9M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 123% increase compared to previous year.

Compensation breakdown

Option Awards$3,300,545
Salary$552,000
Other$8,616
Total$3,861,161

Perkins received $3.3M in option awards, accounting for 85% of the total pay in 2013.

Perkins also received $552K in salary and $8.6K in other compensation.

Rankings

In 2013, Adelene Q. Perkins' compensation ranked 1,839th out of 12,286 executives tracked by ExecPay. In other words, Perkins earned more than 85.0% of executives.

ClassificationRankingPercentile
All
1,839
out of 12,286
85th
Division
Manufacturing
604
out of 4,612
87th
Major group
Chemicals And Allied Products
164
out of 1,462
89th
Industry group
Drugs
111
out of 1,156
90th
Industry
Pharmaceutical Preparations
95
out of 890
89th
Source: SEC filing on April 25, 2016.

Perkins' colleagues

We found four more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2013.

2013

Julian Adams

Infinity Pharmaceuticals

President of R&D

2013

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2013

Lawrence Bloch

Infinity Pharmaceuticals

Chief Financial Officer

2013

David Roth

Infinity Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like